EUVIMEDEUVIMED entdecken
Open Access

Frequency of variants in Mendelian Alzheimer's disease genes within the Alzheimer's Disease Sequencing Project

Dongyu Wang iD, Alexandra Scalici iD, Yanbing Wang iD, Honghuang Lin iD, Achilleas Pitsillides iD, Nancy Heard-Costa iD, Carlos Cruchaga iD, Ellen Ziegemeier iD, Joshua C Bis iD, Myriam Fornage, Eric Boerwinkle iD, Philip L De Jager und 8 weitere

Journal of Alzheimer’s Disease · 2025-04 · 104 (3) · 841-851

DOI: 10.1177/13872877251320375 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, online erschienen am 14.03.2025. Verfasst von Dongyu Wang und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Presenilin-2, Presenilin-1, Amyloid beta-Protein Precursor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Prior studies examined variants within presenilin-2 ( PSEN2 ), presenilin-1 ( PSEN1 ), and amyloid precursor protein ( APP ) genes. However, previously-reported clinically-relevant variants and other predicted damaging missense (DM) variants have not been characterized in a newer release of the Alzheimer's Disease Sequencing Project (ADSP).

Objective

To characterize previously-reported clinically-relevant variants and DM variants in PSEN2, PSEN1, APP within the participants from the ADSP.

Methods

We identified rare variants (MAF < 1%) in PSEN2 , PSEN1, and APP in 14,641 individuals with whole genome sequencing and 16,849 individuals with whole exome sequencing available (N total = 31,490). We additionally curated variants from ClinVar, OMIM, and Alzforum and report carriers of variants in clinical databases as well as predicted DM variants in these genes.

Results

We detected 31 previously-reported clinically-relevant variants with alternate alleles observed within the ADSP: 4 variants in PSEN2 , 25 in PSEN1 , and 2 in APP . The overall variant carrier rate for the 31 clinically-relevant variants in the ADSP was 0.3%. We observed that 79.5% of the variant carriers were cases compared to 3.9% were controls. In those with AD, the mean age of onset of AD among carriers of these clinically-relevant variants was 19.6 ± 1.4 years earlier compared with noncarriers (p = 7.8 × 10 −57 ). Additionally, we identified 197 rare variants (MAF < 1%) within ADSP participants not reported in known clinical databases.

Conclusions

A small proportion of individuals in the ADSP are carriers of a previously-reported clinically-relevant variant allele for AD and these participants have significantly earlier age of AD onset compared to noncarriers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseasePresenilin-2Presenilin-1Amyloid beta-Protein PrecursorGenetic VariationHumansMaleExome SequencingFemaleGene FrequencyWhole Genome SequencingGenetic Predisposition to DiseaseAged

Stichwörter der Autor:innen

Alzheimer's diseasegenetic databasesgenetic profilewhole exome sequencingwhole genome sequencing

Substanzen

Presenilin-2Presenilin-1Amyloid beta-Protein PrecursorPSEN2 protein, humanPSEN1 protein, humanAPP protein, human

Autor:innen und Institutionen

  • Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
  • Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA.
  • Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
  • NHLBI Framingham Heart Study, Framingham, MA, USA.
  • Department of Psychiatry, Washington University School of Medicine, St Louis, MO, USA.
  • Hope Center for Neurological Disorders, Washington University School of Medicine, St Louis, MO, USA.

ORCID-Profile: Dongyu Wang, Alexandra Scalici, Yanbing Wang, Honghuang Lin, Achilleas Pitsillides, Nancy Heard-Costa, Carlos Cruchaga, Ellen Ziegemeier, Joshua C Bis, Eric Boerwinkle, Josée Dupuis, Sudha Seshadri, Alison M Goate, Anita L DeStefano, Gina M Peloso

Förderung

  • NIA NIH HHS
  • NIA

Zitieren

APA

Wang, D., Scalici, A., Wang, Y., Lin, H., Pitsillides, A., Heard-Costa, N., Cruchaga, C., Ziegemeier, E., Bis, J. C., Fornage, M., Boerwinkle, E., De Jager, P. L., Wijsman, E., Dupuis, J., Renton, A. E., Seshadri, S., Goate, A. M., Alzheimer's Disease Neuroimaging Initiative (ADNI), The Alzheimer's Disease Sequencing Project, DeStefano, A. L., & Peloso, G. M. (2025). Frequency of variants in Mendelian Alzheimer's disease genes within the Alzheimer's Disease Sequencing Project. Journal of Alzheimer’s Disease, 104(3), 841-851. https://doi.org/10.1177/13872877251320375

Vancouver

Wang D, Scalici A, Wang Y, Lin H, Pitsillides A, Heard-Costa N, et al. Frequency of variants in Mendelian Alzheimer's disease genes within the Alzheimer's Disease Sequencing Project. Journal of Alzheimer’s Disease. 2025;104(3):841-851. doi:10.1177/13872877251320375

BibTeX
@article{Wang2025,
  author = {Wang, Dongyu and Scalici, Alexandra and Wang, Yanbing and Lin, Honghuang and Pitsillides, Achilleas and Heard-Costa, Nancy and Cruchaga, Carlos and Ziegemeier, Ellen and Bis, Joshua C and Fornage, Myriam and Boerwinkle, Eric and De Jager, Philip L and Wijsman, Ellen and Dupuis, Josée and Renton, Alan E and Seshadri, Sudha and Goate, Alison M and Alzheimer's Disease Neuroimaging Initiative (ADNI), The Alzheimer's Disease Sequencing Project, Alzheimer's Disease Neuroimaging Initiative (ADNI), The Alzheimer's Disease Sequencing Project and DeStefano, Anita L and Peloso, Gina M},
  title = {Frequency of variants in Mendelian Alzheimer's disease genes within the Alzheimer's Disease Sequencing Project},
  journal = {Journal of Alzheimer’s Disease},
  year = {2025},
  volume = {104},
  number = {3},
  pages = {841--851},
  doi = {10.1177/13872877251320375}
}
Kostenlos starten →